Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 18 results for "praful bohra"

Market size for Natco's Sorafenib drug is sub $100 mn: Religare

While the Sorafenib drug is not a big opportunity for Natco, approval from Kothur plant is a big positive, says Praful Bohra of Religare Capital Markets. Money Control, 1 month ago
Hindu Business Line

Stocks in focus: JBM Auto, Wipro, Piramal, Aurobindo, Glenmark, Cadila, FTIL

Shares of components maker JBM Auto today surged over 17 per cent after the company said it will invest Rs 300 crore for developing and manufacturing electric as well as hybrid buses in India through its joint venture with Poland's Solaris Bus & ...
 Hindu Business Line1 week ago
Sify

Pharma stocks hit 4-month high; Nifty Pharma Index gains 1.13%

Stock of pharmaceutical companies jumped on Wednesday with the Nifty Pharma Index gaining as much as 1.13 per cent, its biggest in nearly four months after a US judge refused to issue a temporary restraining order blocking approval of new generic ...
 Economic Times1 week ago Pharma stocks up; US judge refuses to block generics of AstraZeneca's Crestor  Sify1 week ago Aurobindo Pharma keeps up pace  Smart Investor1 month ago Sun Pharma Shares Sink Nearly 7%, Inch Closer To 52-Week Low  NDTV Profit1 month ago

Govt agencies supplied spurious seeds to farmers

Nagpur: Former food and civil supplies minister and Nationalist Congress Party (NCP) leader Anil Deshmukh has alleged that seeds supplied by the government agencies to farmers as part of a relief measure have turned out to be spurious as they failed ...
 Times of India1 week ago
India TV

Pharma sector grows 7.7% in May; FDC ban weighs

Mumbai, Jun 12 () Indian pharmaceutical market grew 7.7 per cent in May compared with 3.5 per cent in April, but the ban on fixed-dose combination (FDC) drugs remains an overhang, says a report. According to data from the AIOCD-AWACS, the market ...
 Times of India1 month ago Pharma sector grows 7.7 per cent in May; FDC ban weighs  Pharmaceutical Tech.com1 month ago Pharma Sector Grows 7.7% In May, Drug Ban Weighs: Report  NDTV1 month ago Pharma sector grows 7.7% in May, FDC ban weighs  Financial Express1 month ago
[x]  

Investors Overlook Lupin's Q4 Beat, Shares Tumble Over 9%

Lupin's Goa plant is under US drug regulator's scanner Lupin shares sank over 8 per cent on Friday, even though analysts described the drugmaker's Q4 results as positive. Lupin, India's third-largest drugmaker, reported a higher than expected ...
 NDTV Profit2 months ago Goa plant woes a key overhang on Lupin: Experts  Moneycontrol.com2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less